BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25987376)

  • 1. DNA specific fluorescent symmetric dimeric bisbenzimidazoles DBP(n): the synthesis, spectral properties, and biological activity.
    Ivanov AA; Koval VS; Susova OY; Salyanov VI; Oleinikov VA; Stomakhin AA; Shalginskikh NA; Kvasha MA; Kirsanova OV; Gromova ES; Zhuze AL
    Bioorg Med Chem Lett; 2015 Jul; 25(13):2634-8. PubMed ID: 25987376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [DNA sequence-specific ligands: XIV. Synthesis of fluorescent biologicaly active dimeric bisbenzimidazoles-DB(3, 4, 5, 7, 11)].
    Ivanov AA; Salianov VI; Strel'tsov SA; Cherepanova NA; Gromova ES; Zhuze AL
    Bioorg Khim; 2011; 37(4):530-41. PubMed ID: 22096996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of complex formation between monomeric and dimeric bisbenzimidazoles and AT-containing polynucleotide].
    Lisitsina ES; Durandin NA; Ivanov AA; Strel'tsov SA; Susova OIu; Shtil' AA; Zhuze AL; Kuz'min VA
    Mol Biol (Mosk); 2012; 46(6):922-7. PubMed ID: 23350239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA sequence-specific ligands. XVIII. Synthesis, physico-chemical properties; genetic, virological, and biochemical studies of fluorescent dimeric bisbenzimidazoles DBPA(n).
    Koval VS; Arutyunyan AF; Salyanov VI; Kostyukov AA; Melkina OE; Zavilgelsky GB; Klimova RR; Kushch AA; Korolev SP; Agapkina YY; Gottikh MB; Vaiman AV; Rybalkina EY; Susova OY; Zhuze AL
    Bioorg Med Chem; 2020 Apr; 28(7):115378. PubMed ID: 32089391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minor groove dimeric bisbenzimidazoles inhibit in vitro DNA binding to eukaryotic DNA topoisomerase I.
    Susova OY; Ivanov AA; Morales Ruiz SS; Lesovaya EA; Gromyko AV; Streltsov SA; Zhuze AL
    Biochemistry (Mosc); 2010 Jun; 75(6):695-701. PubMed ID: 20636260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimeric bisbenzimidazoles inhibit the DNA methylation catalyzed by the murine Dnmt3a catalytic domain.
    Cherepanova NA; Ivanov AA; Maltseva DV; Minero AS; Gromyko AV; Streltsov SA; Zhuze AL; Gromova ES
    J Enzyme Inhib Med Chem; 2011 Apr; 26(2):295-300. PubMed ID: 20615081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA sequence-specific dimeric bisbenzimidazoles DBP(n) and DBPA(n) as inhibitors of H-NS silencing in bacterial cells.
    Melkina OE; Koval VS; Ivanov AA; Zhuze AL; Zavilgelsky GB
    Microbiol Res; 2018 Mar; 207():75-82. PubMed ID: 29458871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA sequence-specific ligands. XVII. Synthesis, spectral properties, virological and biochemical studies of fluorescent dimeric bisbenzimidazoles DBA(n).
    Koval VS; Arutyunyan AF; Salyanov VL; Klimova RR; Kushch AA; Rybalkina EY; Susova OY; Zhuze AL
    Bioorg Med Chem; 2018 May; 26(9):2302-2309. PubMed ID: 29602675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-aryl-substituted 2-bis-1H-benzimidazoles.
    Singh M; Tandon V
    Eur J Med Chem; 2011 Feb; 46(2):659-69. PubMed ID: 21186067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatic analogues of DNA minor groove binders--synthesis and biological evaluation.
    Pućkowska A; Bielawski K; Bielawska A; Midura-Nowaczek K
    Eur J Med Chem; 2004 Jan; 39(1):99-105. PubMed ID: 14987838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis and properties of a symmetric dimeric bisbenzimidazole, a DNA-specific ligand].
    Ivanov AA; Strel'tsov SA; Prikazchikova TA; Gottikh MB; Zhuze AL
    Bioorg Khim; 2008; 34(2):285-8. PubMed ID: 18522287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gram-negative synergy and mechanism of action of alkynyl bisbenzimidazoles.
    Chamberlin J; Story S; Ranjan N; Chesser G; Arya DP
    Sci Rep; 2019 Oct; 9(1):14171. PubMed ID: 31578425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.
    Genès C; Lenglet G; Depauw S; Nhili R; Prado S; David-Cordonnier MH; Michel S; Tillequin F; Porée FH
    Eur J Med Chem; 2011 Jun; 46(6):2117-31. PubMed ID: 21435753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and antiproliferative evaluation of fluorenone analogs with DNA topoisomerase I inhibitory properties.
    Lee CC; Chang DM; Huang KF; Chen CL; Chen TC; Lo Y; Guh JH; Huang HS
    Bioorg Med Chem; 2013 Nov; 21(22):7125-33. PubMed ID: 24094433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dimeric bisbenzimidazoles suppress the herpes simplex virus and human cytomegalovirus infections in cell сultures].
    Klimova RR; Momotyuk ED; Demidova NA; Chernoryzh YY; Koval VS; Ivanov AA; Zhuze AL; Kushch AA
    Vopr Virusol; 2017; 62(4):162-168. PubMed ID: 29733165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and anti-tumor evaluation of novel symmetrical bis-benzimidazoles.
    Yang YH; Cheng MS; Wang QH; Nie H; Liao N; Wang J; Chen H
    Eur J Med Chem; 2009 Apr; 44(4):1808-12. PubMed ID: 18762358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symmetric dimeric bisbenzimidazoles DBP(n) reduce methylation of RARB and PTEN while significantly increase methylation of rRNA genes in MCF-7 cancer cells.
    Kostyuk SV; Kvasha MA; Khrabrova DA; Kirsanova OV; Ershova ES; Malinovskaya EM; Veiko NN; Ivanov AA; Koval VS; Zhuze AL; Tashlitsky VH; Umriukhin PE; Kutsev SI; Gromova ES
    PLoS One; 2018; 13(1):e0189826. PubMed ID: 29329300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-proline analogues of anthraquinone-2-carboxylic acid: cytotoxic activity in breast cancer MCF-7 cells and inhibitory activity against topoisomerase I and II.
    Bielawska A; Kosk K; Bielawski K
    Pol J Pharmacol; 2001; 53(3):283-7. PubMed ID: 11785929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Inhibition of Escherichia coli RNA and DNA Topoisomerase I by Hoechst 33258 Derived Mono- and Bisbenzimidazoles.
    Ranjan N; Story S; Fulcrand G; Leng F; Ahmad M; King A; Sur S; Wang W; Tse-Dinh YC; Arya DP
    J Med Chem; 2017 Jun; 60(12):4904-4922. PubMed ID: 28513176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel benzoxanthone analogues as non-Camptothecin topoisomerase I inhibitors.
    Cheng P; Zhu L; Guo W; Liu W; Yao J; Dong G; Zhang Y; Zhuang C; Sheng C; Miao Z; Zhang W
    J Enzyme Inhib Med Chem; 2012 Jun; 27(3):437-42. PubMed ID: 21770860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.